Lifecore Biomedical to Participate in Upcoming Investor Conferences
Lifecore Biomedical (NASDAQ: LFCR), a contract development and manufacturing organization (CDMO), has announced its participation in three upcoming investor conferences in September 2025.
The company will participate in the Morgan Stanley Global Healthcare Conference (Sept 8-10) featuring a fireside chat, the Barrington Research Virtual Fall Investment Conference (Sept 16), and the Jefferies CDMO Summit (Sept 17). The Morgan Stanley fireside chat will be webcast live and available for replay on Lifecore's investor website.
Lifecore Biomedical (NASDAQ: LFCR), un'organizzazione di sviluppo e produzione a contratto (CDMO), ha annunciato la partecipazione a tre conferenze per investitori previste per settembre 2025.
L'azienda parteciper脿 al Morgan Stanley Global Healthcare Conference (8-10 settembre) con un fireside chat, al Barrington Research Virtual Fall Investment Conference (16 settembre) e al Jefferies CDMO Summit (17 settembre). Il fireside chat di Morgan Stanley sar脿 trasmesso in diretta e rester脿 disponibile in replay nella sezione investor del sito di Lifecore.
Lifecore Biomedical (NASDAQ: LFCR), una organizaci贸n de desarrollo y fabricaci贸n por contrato (CDMO), ha anunciado su participaci贸n en tres conferencias para inversores en septiembre de 2025.
La compa帽铆a asistir谩 al Morgan Stanley Global Healthcare Conference (8-10 de septiembre) con un fireside chat, al Barrington Research Virtual Fall Investment Conference (16 de septiembre) y al Jefferies CDMO Summit (17 de septiembre). El fireside chat de Morgan Stanley se retransmitir谩 en directo y quedar谩 disponible en replay en la secci贸n de inversores del sitio web de Lifecore.
Lifecore Biomedical (NASDAQ: LFCR))電� 瓿勳暯 臧滊皽路鞝滌“ 旮瓣磤(CDMO)鞙茧靹� 2025雲� 9鞗旍棎 鞓堨爼霅� 靹� 瓯挫潣 韴瀽鞛� 旎嵓霟办姢 彀戈皜毳� 氚滍憸頄堨姷雼堧嫟.
須岇偓 旄§潃 Morgan Stanley Global Healthcare Conference(9鞗� 8鈥�10鞚�)鞐愳劀 韺岇澊鞏挫偓鞚措摐 毂楈棎 彀胳棳頃橂┌, Barrington Research Virtual Fall Investment Conference(9鞗� 16鞚�)鞕� Jefferies CDMO Summit(9鞗� 17鞚�)鞐愲弰 彀胳劃頃� 鞓堨爼鞛呺媹雼�. 氇贝鞀ろ儬毽潣 韺岇澊鞏挫偓鞚措摐 毂楈潃 霛检澊敫� 鞗轨簮鞀ろ姼搿� 靻§稖霅橂┌ Lifecore 韴瀽鞛� 鞗轨偓鞚错姼鞐愳劀 雼れ嫓氤搓赴搿� 鞝滉车霅╇媹雼�.
Lifecore Biomedical (NASDAQ: LFCR), une organisation de d茅veloppement et de fabrication sous contrat (CDMO), a annonc茅 sa participation 脿 trois conf茅rences investisseurs pr茅vues en septembre 2025.
La soci茅t茅 participera au Morgan Stanley Global Healthcare Conference (8-10 septembre) avec un fireside chat, au Barrington Research Virtual Fall Investment Conference (16 septembre) et au Jefferies CDMO Summit (17 septembre). Le fireside chat de Morgan Stanley sera diffus茅 en direct et restera disponible en replay sur la page investisseurs de Lifecore.
Lifecore Biomedical (NASDAQ: LFCR), eine Auftragsentwicklungs- und -herstellungsorganisation (CDMO), hat seine Teilnahme an drei bevorstehenden Investorenkonferenzen im September 2025 angek眉ndigt.
Das Unternehmen wird an der Morgan Stanley Global Healthcare Conference (8.鈥�10. Sept.) mit einem Fireside-Chat teilnehmen, am Barrington Research Virtual Fall Investment Conference (16. Sept.) sowie am Jefferies CDMO Summit (17. Sept.). Der Fireside-Chat bei Morgan Stanley wird live als Webcast 眉bertragen und auf der Investorenseite von Lifecore als Aufzeichnung verf眉gbar sein.
- None.
- None.
CHASKA, Minn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (鈥淟ifecore鈥�), a fully integrated contract development and manufacturing organization (鈥淐DMO鈥�), today announced that the company will participate in multiple upcoming investor conferences. Details regarding Lifecore鈥檚 participation are as follows:
- Morgan Stanley 23rd Annual Global Healthcare Conference
Details: Lifecore management will participate in a fireside chat and in investor meetings
Conference Dates: September 8-10, 2025
Fireside Chat Time: 4:50 鈥� 5:25 p.m. Eastern on Tuesday, September 9, 2025, webcast available
Location: New York, NY
- Barrington Research Virtual Fall Investment Conference
Details: Lifecore management will participate in investor meetings
Conference Date: September 16, 2025
Location: Virtual
- Jefferies CDMO Summit 2025
Details: Lifecore management will participate in investor meetings
Conference Date: September 17, 2025
Location: London, UK
A live webcast of the Morgan Stanley fireside chat may be accessed via a link on Lifecore鈥檚 investor website on the Investor Events & Presentations page at:聽. Additionally, a replay of the webcast will be available on the Lifecore website following the conference.
About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: ) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore鈥檚 website at .
Lifecore Biomedical, Inc. Contact Information: Vida Strategic Partners Stephanie Diaz (Investors) 415-675-7401 [email protected]聽 Tim Brons (Media) 415-675-7402 [email protected]聽 Ryan D. Lake (CFO) Lifecore Biomedical 952-368-6244 [email protected]
FAQ
When is Lifecore Biomedical's (LFCR) fireside chat at the Morgan Stanley Healthcare Conference 2025?
How can investors access Lifecore Biomedical's Morgan Stanley conference presentation?
Which investor conferences will Lifecore Biomedical (LFCR) attend in September 2025?
Where will the Lifecore Biomedical investor conferences be held?
